Literature DB >> 1658396

Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.

G Dubin1, E Socolof, I Frank, H M Friedman.   

Abstract

Recent studies indicate that the herpes simplex virus type 1 (HSV-1) Fc receptor (FcR) can bind antiviral immunoglobulin G by participating in antibody bipolar bridging. This occurs when the Fab domain of an immunoglobulin G molecule binds to its antigenic target and the Fc domain binds to the HSV-1 FcR. In experiments comparing cells infected with wild-type HSV-1 (NS) and cells infected with an FcR-deficient mutant (ENS), we demonstrate that participation of the HSV-1 FcR in antibody bipolar bridging reduces the effectiveness of antibody-dependent cellular cytotoxicity.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1658396      PMCID： PMC250825     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  37 in total

1.  A fragment corresponding to the C(H)2 region of immunoglobulin G (IgG) with complement fixing activity.

Authors:  J R. Ellerson; D Yasmeen; R H. Painter; K J. Dorrington
Journal:  FEBS Lett       Date:  1972-08-15       Impact factor: 4.124

2.  Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein.

Authors:  R B Baucke; P G Spear
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

3.  Herpes simplex virus IgG Fc receptors induced using recombinant adenovirus vectors expressing glycoproteins E and I.

Authors:  T Hanke; F L Graham; V Lulitanond; D C Johnson
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

4.  Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.

Authors:  T Lehner; J M Wilton; E J Shillitoe
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

5.  Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes.

Authors:  G Dubin; I Frank; H M Friedman
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1.

Authors:  S Bell; M Cranage; L Borysiewicz; T Minson
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor.

Authors:  V Litwin; M Sandor; C Grose
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

8.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

9.  Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein.

Authors:  M F Para; L Goldstein; P G Spear
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

10.  Receptor for immunoglobulin Fc on pathogenic but not on nonpathogenic protozoa of the Trypanosomatidae.

Authors:  I K De Miranda-Santos; A Campos-Neto
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307
View more
  63 in total

1.  Herpes simplex virus vectors elicit durable immune responses in the presence of preexisting host immunity.

Authors:  Mark A Brockman; David M Knipe
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.

Authors:  K E Van Vliet; L A De Graaf-Miltenburg; J Verhoef; J A Van Strijp
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

4.  Immunoglobulin genes and immunity to herpes simplex virus type 1.

Authors:  Janardan P Pandey
Journal:  J Infect Dis       Date:  2012-04-25       Impact factor: 5.226

5.  The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors.

Authors:  Katarina Polcicova; Kim Goldsmith; Barb L Rainish; Todd W Wisner; David C Johnson
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells.

Authors:  Hong-Sheng Dai; Nathaniel Griffin; Chelsea Bolyard; Hsiaoyin Charlene Mao; Jianying Zhang; Timothy P Cripe; Tadahiro Suenaga; Hisashi Arase; Ichiro Nakano; E A Chiocca; Balveen Kaur; Jianhua Yu; Michael A Caligiuri
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

7.  Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs.

Authors:  Ramazan Atalay; Albert Zimmermann; Markus Wagner; Eva Borst; Christine Benz; Martin Messerle; Hartmut Hengel
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor.

Authors:  R Thäle; P Lucin; K Schneider; M Eggers; U H Koszinowski
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein.

Authors:  B N Lilley; H L Ploegh; R S Tirabassi
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

10.  A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.

Authors:  Elizabeth E Brittle; Fushan Wang; John M Lubinski; Ralph M Bunte; Harvey M Friedman
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.